JP2012130342A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012130342A5 JP2012130342A5 JP2012009515A JP2012009515A JP2012130342A5 JP 2012130342 A5 JP2012130342 A5 JP 2012130342A5 JP 2012009515 A JP2012009515 A JP 2012009515A JP 2012009515 A JP2012009515 A JP 2012009515A JP 2012130342 A5 JP2012130342 A5 JP 2012130342A5
- Authority
- JP
- Japan
- Prior art keywords
- side region
- nucleic acid
- acid molecule
- stranded rna
- bases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 39
- 230000014509 gene expression Effects 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 14
- 230000001629 suppression Effects 0.000 claims description 10
- 230000009368 gene silencing by RNA Effects 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims 14
- 108090000623 proteins and genes Proteins 0.000 claims 7
- 230000001939 inductive effect Effects 0.000 claims 4
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 claims 3
- 238000000338 in vitro Methods 0.000 claims 3
- 230000000295 complement effect Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000002585 base Substances 0.000 description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012009515A JP5804642B2 (ja) | 2010-07-08 | 2012-01-20 | 遺伝子発現制御のための一本鎖核酸分子 |
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010156122 | 2010-07-08 | ||
| JP2010156122 | 2010-07-08 | ||
| JP2010174915 | 2010-08-03 | ||
| JP2010174915 | 2010-08-03 | ||
| JP2010230806 | 2010-10-13 | ||
| JP2010230806 | 2010-10-13 | ||
| JP2010230808 | 2010-10-13 | ||
| JP2010230808 | 2010-10-13 | ||
| JP2010269823 | 2010-12-02 | ||
| JP2010269823 | 2010-12-02 | ||
| JP2010269824 | 2010-12-02 | ||
| JP2010269824 | 2010-12-02 | ||
| JP2012009515A JP5804642B2 (ja) | 2010-07-08 | 2012-01-20 | 遺伝子発現制御のための一本鎖核酸分子 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011537086A Division JP4968811B2 (ja) | 2010-07-08 | 2011-07-08 | 遺伝子発現制御のための一本鎖核酸分子 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015150156A Division JP6162182B2 (ja) | 2010-07-08 | 2015-07-29 | 遺伝子発現制御のための一本鎖核酸分子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012130342A JP2012130342A (ja) | 2012-07-12 |
| JP2012130342A5 true JP2012130342A5 (enExample) | 2013-10-03 |
| JP5804642B2 JP5804642B2 (ja) | 2015-11-04 |
Family
ID=45441339
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011537086A Expired - Fee Related JP4968811B2 (ja) | 2010-07-08 | 2011-07-08 | 遺伝子発現制御のための一本鎖核酸分子 |
| JP2012009515A Expired - Fee Related JP5804642B2 (ja) | 2010-07-08 | 2012-01-20 | 遺伝子発現制御のための一本鎖核酸分子 |
| JP2015150156A Expired - Fee Related JP6162182B2 (ja) | 2010-07-08 | 2015-07-29 | 遺伝子発現制御のための一本鎖核酸分子 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011537086A Expired - Fee Related JP4968811B2 (ja) | 2010-07-08 | 2011-07-08 | 遺伝子発現制御のための一本鎖核酸分子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015150156A Expired - Fee Related JP6162182B2 (ja) | 2010-07-08 | 2015-07-29 | 遺伝子発現制御のための一本鎖核酸分子 |
Country Status (17)
| Country | Link |
|---|---|
| EP (2) | EP2933333B1 (enExample) |
| JP (3) | JP4968811B2 (enExample) |
| KR (1) | KR101849798B1 (enExample) |
| CN (2) | CN102918156B (enExample) |
| AU (1) | AU2011274854B2 (enExample) |
| BR (1) | BR112013000481A2 (enExample) |
| CA (1) | CA2804511C (enExample) |
| DK (2) | DK2431466T3 (enExample) |
| ES (2) | ES2670017T3 (enExample) |
| HU (2) | HUE037500T2 (enExample) |
| MX (1) | MX352568B (enExample) |
| NZ (2) | NZ606232A (enExample) |
| PT (2) | PT2933333T (enExample) |
| RU (1) | RU2628311C2 (enExample) |
| SG (2) | SG186899A1 (enExample) |
| TW (2) | TWI527901B (enExample) |
| WO (1) | WO2012005368A1 (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8691782B2 (en) | 2010-08-03 | 2014-04-08 | Bonac Corporation | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton |
| WO2013077446A1 (ja) * | 2011-11-26 | 2013-05-30 | 株式会社ボナック | 遺伝子発現制御のための一本鎖核酸分子 |
| WO2013133393A1 (ja) * | 2012-03-07 | 2013-09-12 | 学校法人東京医科大学 | Ｖｅｇｆ遺伝子の発現抑制用一本鎖核酸分子 |
| TW201343668A (zh) | 2012-03-29 | 2013-11-01 | Univ Kyushu Nat Univ Corp | 成骨細胞特異因子（ｐｅｒｉｏｓｔｉｎ）基因之表現抑制核酸分子、成骨細胞特異因子基因之表現抑制方法及其用途 |
| US9663784B2 (en) | 2012-05-26 | 2017-05-30 | Bonac Corporation | Single-stranded nucleic acid molecule for regulating expression of gene having delivering function |
| EP3088524A4 (en) | 2013-12-26 | 2017-08-09 | Tokyo Medical University | Artificial mimic mirna for controlling gene expression, and use of same |
| KR102357337B1 (ko) | 2013-12-27 | 2022-01-28 | 가부시키가이샤 보낙 | 유전자 발현 제어를 위한 인공 매치형 miRNA 및 그 용도 |
| US10337009B2 (en) | 2014-12-15 | 2019-07-02 | Bonac Corporation | Single-stranded nucleic acid molecule for inhibiting TGF-β1 expression |
| SG11201705223XA (en) | 2014-12-27 | 2017-07-28 | Bonac Corp | NATURALLY OCCURING miRNA FOR CONTROLLING GENE EXPRESSION, AND USE OF SAME |
| WO2016158809A1 (ja) | 2015-03-27 | 2016-10-06 | 株式会社ボナック | デリバリー機能と遺伝子発現制御能を有する一本鎖核酸分子 |
| CA3002786C (en) * | 2015-10-30 | 2021-09-07 | Bonac Corporation | Composition stably containing single-stranded nucleic acid molecule that suppresses expression of tgf-.beta.1 gene |
| KR102116922B1 (ko) | 2015-12-29 | 2020-06-01 | 내셔널 유니버시티 코포레이션 홋카이도 유니버시티 | 프로레닌 유전자 또는 프로레닌 수용체 유전자의 발현을 억제하는 일본쇄 핵산 분자 및 이의 용도 |
| CA3013179A1 (en) | 2016-01-30 | 2017-08-03 | Bonac Corporation | Artificial single guide rna and use thereof |
| WO2018182008A1 (ja) | 2017-03-31 | 2018-10-04 | 株式会社ボナック | 遺伝子発現制御機能を有する環状型核酸分子 |
| JPWO2018199338A1 (ja) * | 2017-04-27 | 2020-03-12 | 国立大学法人広島大学 | Ｂ型肝炎治療用核酸分子 |
| EA202090393A1 (ru) | 2017-07-28 | 2020-05-20 | Кёрин Фармасьютикал Ко., Лтд. | Терапевтическое средство от фиброза |
| KR20250035034A (ko) * | 2017-09-15 | 2025-03-11 | 커먼웰쓰 사이언티픽 앤드 인더스트리얼 리서치 오가니제이션 | Rna 분자 |
| WO2019074071A1 (ja) | 2017-10-11 | 2019-04-18 | 日東電工株式会社 | 核酸分子発現の調節 |
| WO2019074110A1 (ja) | 2017-10-13 | 2019-04-18 | 株式会社ボナック | 一本鎖核酸分子およびその製造方法 |
| TWI830718B (zh) * | 2018-02-09 | 2024-02-01 | 日商住友化學股份有限公司 | 核酸分子之製造方法 |
| US11920131B2 (en) | 2018-03-30 | 2024-03-05 | Toray Industries, Inc. | Method of producing hairpin single-stranded RNA molecule |
| EP3778914A4 (en) | 2018-03-30 | 2022-01-19 | Sumitomo Chemical Company, Ltd. | Method for producing single-strand rna |
| EP3862431B1 (en) | 2018-10-02 | 2024-06-26 | Toray Industries, Inc. | Method for producing hairpin single-strand rna molecules |
| EP3915567A4 (en) | 2019-01-25 | 2022-09-21 | Kyorin Pharmaceutical Co., Ltd. | Therapeutic agent for fibrosis |
| CN114502566B (zh) | 2019-10-11 | 2025-02-11 | 住友化学株式会社 | 核酸寡聚物的制造方法 |
| WO2021153047A1 (ja) | 2020-01-29 | 2021-08-05 | 住友化学株式会社 | 核酸オリゴマーの製造方法 |
| KR20220133919A (ko) | 2020-01-29 | 2022-10-05 | 스미또모 가가꾸 가부시끼가이샤 | 핵산 올리고머의 제조 방법 |
| JP7613130B2 (ja) * | 2020-03-25 | 2025-01-15 | 味の素株式会社 | リガーゼ変異体 |
| JP7698631B2 (ja) | 2020-03-27 | 2025-06-25 | 住友化学株式会社 | 核酸オリゴマーの製造方法 |
| US20230242570A1 (en) | 2020-07-09 | 2023-08-03 | Sumitomo Chemical Company, Limited | Method for producing nucleic acid oligomer |
| JP7719788B2 (ja) | 2020-09-24 | 2025-08-06 | 住友化学株式会社 | 核酸オリゴマーの製造方法 |
| EP4410770A1 (en) | 2021-09-28 | 2024-08-07 | Sumitomo Chemical Company, Limited | Production method for purified dichloroacetic acid |
| KR20240162536A (ko) | 2022-03-23 | 2024-11-15 | 스미또모 가가꾸 가부시끼가이샤 | 핵산 올리고머의 제조 방법 |
| JP7201190B1 (ja) | 2022-06-03 | 2023-01-10 | 株式会社セツロテック | 遺伝子改変動物由来の動物繊維 |
| US20250136632A1 (en) | 2022-10-27 | 2025-05-01 | Sumitomo Chemical Company, Limited | Method for producing oligonucleotide |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3687808A (en) | 1969-08-14 | 1972-08-29 | Univ Leland Stanford Junior | Synthetic polynucleotides |
| US5631148A (en) * | 1994-04-22 | 1997-05-20 | Chiron Corporation | Ribozymes with product ejection by strand displacement |
| US6509323B1 (en) | 1998-07-01 | 2003-01-21 | California Institute Of Technology | Linear cyclodextrin copolymers |
| FR2790757B1 (fr) * | 1999-03-09 | 2003-08-01 | Bioalliance Pharma | Oligonucleotides contenant une sequence antisens stabilises par une structure secondaire et compositions pharmaceutiques les contenant. |
| TWI321054B (en) | 2000-12-19 | 2010-03-01 | California Inst Of Techn | Compositions containing inclusion complexes |
| US20060111312A1 (en) * | 2002-02-22 | 2006-05-25 | The John Hopkins University | Antigene locks and therapeutic uses thereof |
| ES2280826T5 (es) * | 2002-08-05 | 2017-08-03 | Silence Therapeutics Gmbh | Nuevas formas adicionales de moléculas de ARN de interferencia |
| AU2003256857A1 (en) * | 2002-08-08 | 2004-02-25 | Dharmacon, Inc. | Short interfering rnas having a hairpin structure containing a non-nucleotide loop |
| AU2004276684A1 (en) * | 2003-09-30 | 2005-04-07 | Anges Mg, Inc. | Staple type oligonucleotide and drug comprising the same |
| JP2008504840A (ja) * | 2004-06-30 | 2008-02-21 | アルニラム ファーマスーティカルズ インコーポレイテッド | 非リン酸骨格結合を含むオリゴヌクレオチド |
| EP1838875A4 (en) * | 2004-12-30 | 2010-08-25 | Todd M Hauser | COMPOSITIONS AND METHODS FOR MODULATING GENE EXPRESSION USING SELF-PROTECTED OLIGONUCLEOTIDES |
| WO2007108621A1 (en) * | 2006-03-17 | 2007-09-27 | Bioneer Corporation | Sirna for inhibiting nf-kb/rela expression |
| JP5296328B2 (ja) * | 2007-05-09 | 2013-09-25 | 独立行政法人理化学研究所 | １本鎖環状ｒｎａおよびその製造方法 |
| WO2009074076A1 (en) * | 2007-11-29 | 2009-06-18 | Suzhou Ribo Life Science Co., Ltd | A complex molecule interfering the expression of target genes and its preparing methods |
| US20110159586A1 (en) * | 2007-12-07 | 2011-06-30 | Halo-Bio Rnai Therapeutics, Inc. | Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides |
| WO2009102081A1 (ja) * | 2008-02-15 | 2009-08-20 | Riken | 環状１本鎖核酸複合体およびその製造方法 |
| JP5187580B2 (ja) | 2008-12-26 | 2013-04-24 | 丸紅建材リース株式会社 | 掘削機の泥土飛散防止装置 |
| JP2010174915A (ja) | 2009-01-27 | 2010-08-12 | Toyota Motor Corp | 高圧ガスタンク |
| JP5233790B2 (ja) | 2009-03-26 | 2013-07-10 | 船井電機株式会社 | 液晶モジュール |
| JP5449815B2 (ja) | 2009-03-26 | 2014-03-19 | 住友化学株式会社 | 偏光板の製造方法 |
| JP4885255B2 (ja) | 2009-05-21 | 2012-02-29 | 株式会社エフピコ | 包装用容器 |
| JP2010269823A (ja) | 2009-05-21 | 2010-12-02 | British American Tobacco Japan Kk | 喫煙品用容器 |
-
2011
- 2011-07-08 ES ES15169933.7T patent/ES2670017T3/es active Active
- 2011-07-08 EP EP15169933.7A patent/EP2933333B1/en active Active
- 2011-07-08 MX MX2013000315A patent/MX352568B/es active IP Right Grant
- 2011-07-08 CN CN201180027223.1A patent/CN102918156B/zh not_active Expired - Fee Related
- 2011-07-08 NZ NZ606232A patent/NZ606232A/en not_active IP Right Cessation
- 2011-07-08 KR KR1020127033429A patent/KR101849798B1/ko active Active
- 2011-07-08 DK DK11746147.5T patent/DK2431466T3/en active
- 2011-07-08 CN CN201510226685.6A patent/CN104818276B/zh not_active Expired - Fee Related
- 2011-07-08 TW TW100124393A patent/TWI527901B/zh not_active IP Right Cessation
- 2011-07-08 TW TW104143857A patent/TWI573870B/zh active
- 2011-07-08 AU AU2011274854A patent/AU2011274854B2/en active Active
- 2011-07-08 WO PCT/JP2011/065737 patent/WO2012005368A1/ja not_active Ceased
- 2011-07-08 BR BR112013000481-9A patent/BR112013000481A2/pt not_active Application Discontinuation
- 2011-07-08 DK DK15169933.7T patent/DK2933333T3/en active
- 2011-07-08 CA CA2804511A patent/CA2804511C/en active Active
- 2011-07-08 SG SG2013000211A patent/SG186899A1/en unknown
- 2011-07-08 HU HUE15169933A patent/HUE037500T2/hu unknown
- 2011-07-08 SG SG2013097233A patent/SG196779A1/en unknown
- 2011-07-08 ES ES11746147.5T patent/ES2550487T3/es active Active
- 2011-07-08 PT PT151699337T patent/PT2933333T/pt unknown
- 2011-07-08 HU HUE11746147A patent/HUE026520T2/en unknown
- 2011-07-08 NZ NZ704812A patent/NZ704812A/en unknown
- 2011-07-08 RU RU2013105329A patent/RU2628311C2/ru active
- 2011-07-08 JP JP2011537086A patent/JP4968811B2/ja not_active Expired - Fee Related
- 2011-07-08 EP EP11746147.5A patent/EP2431466B1/en active Active
- 2011-07-08 PT PT117461475T patent/PT2431466E/pt unknown
-
2012
- 2012-01-20 JP JP2012009515A patent/JP5804642B2/ja not_active Expired - Fee Related
-
2015
- 2015-07-29 JP JP2015150156A patent/JP6162182B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012130342A5 (enExample) | ||
| US12486505B2 (en) | Oligonucleotide compositions and methods thereof | |
| US20240117347A1 (en) | Oligonucleotide compositions and methods thereof | |
| Bhatti et al. | Emerging role of non‐coding RNA in health and disease | |
| US10724035B2 (en) | Oligonucleotide compositions and methods thereof | |
| Van Rooij et al. | MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles | |
| Kesy et al. | A short chemically modified dsRNA-binding PNA (dbPNA) inhibits influenza viral replication by targeting viral RNA panhandle structure | |
| TW202043249A (zh) | 編輯rna的方法和組合物 | |
| JP2012029693A5 (enExample) | ||
| RU2013105329A (ru) | Молекула одноцепочечной нуклеиновой кислоты для контроля экспрессии генов | |
| JP2009159971A5 (enExample) | ||
| EP3942049A1 (en) | Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases | |
| JP2009219504A5 (enExample) | ||
| JP2012050449A5 (enExample) | ||
| JP2017079776A5 (enExample) | ||
| JP2013510561A5 (enExample) | ||
| JP2011500858A5 (enExample) | ||
| CN102433340B (zh) | 家蚕核型多角体病毒抗性关键基因BmPGRP2及其应用 | |
| JP2020532962A (ja) | Ｃａｓヌクレアーゼの特異的活性化のための抗ＣＲＩＳＰＲポリペプチドの使用 | |
| JP2012516856A5 (enExample) | ||
| JP2013537404A5 (enExample) | ||
| Han et al. | Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers | |
| Baud et al. | Partners in crime: Proteins implicated in RNA repeat expansion diseases | |
| Liang et al. | Ring-structured DNA and RNA as key players in vivo and in vitro | |
| Sharma et al. | Engineering circular RNA for molecular and metabolic reprogramming |